Intravitreal Conbercept therapy for choroidal neovascularization due to high myopia
AIM: To evaluate the efficacy and safety of intravitreal injection of Conbercept as the treatment of choroidal neovascularization due to high myopia. <p>METHODS: The study was a retrospective analytical case series. We reviewed medical records of 15 patients(16 eyes)with choroidal neovasculari...
Main Authors: | Yan-Jie Xie, Guo-Ping Duan, Rong Hu, Qi Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2018-02-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://www.ijo.cn/cn_publish/2018/3/201803047.pdf |
Similar Items
-
Efficacy of Conbercept in the Treatment of Choroidal Neovascularization Secondary to Pathologic Myopia
by: Hui Lu, et al.
Published: (2021-10-01) -
Efficacy and safety of intravitreal injections of conbercept for the treatment of idiopathic choroidal neovascularization
by: Gaixia Zhai, et al.
Published: (2024-02-01) -
What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study
by: Liukun Shi, et al.
Published: (2019-06-01) -
Short-term effects of intravitreal Conbercept for choroidal neovascularization secondary to high myopia
by: Jie-Yun He, et al.
Published: (2018-12-01) -
Observation of the macular thickness after the treatment of choroidal neovascularization with pathological myopia
by: Li Yan, et al.
Published: (2018-02-01)